Cite Filings / INTS
Feed Companies Filings Check
Sign in

CIK 0001567264

  • Emerging growth company

INTENSITY THERAPEUTICS, INC.

Sign in to watch
Ticker
INTS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461488089
Phone
+1 203-221-7381
Business address
1 ENTERPRISE DRIVE, SUITE 430, SHELTON, CT, 06484
Filings Financials Insiders Search text
All 246 Financials 61 Shareholder Meetings 5 Executive Compensation 53 Insider Trading 41 Beneficial Ownership Interest 11 Business Combinations 46 Public Offerings 87 Mutual Funds and ETFs 4 Others 45
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-30
  3. DEF 14A Proxy Proxy Statement 2025-09-09
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2025-08-14
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2025-07-09
  6. DEF 14A Proxy Proxy Statement 2025-06-02
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2025-05-15
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership 2025-02-14
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership 2024-12-30
  10. SC 13G Stake Amended Statement of Ownership 2024-06-07
  11. DEF 14A Proxy Proxy Statement 2024-06-04
  12. SC 13G Stake Amended Statement of Ownership 2024-02-13

Page 1 of 1 · 11 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…